Avidan Neumann
Avidan Neumann
Helmholtz Center Munich, University Hospital Augsburg
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα tum.de
Παρατίθεται από
Παρατίθεται από
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
DD Ho, AU Neumann, AS Perelson, W Chen, JM Leonard, M Markowitz
Nature 373 (6510), 123-126, 1995
HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time
AS Perelson, AU Neumann, M Markowitz, JM Leonard, DD Ho
Science 271 (5255), 1582-1586, 1996
Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-α therapy
AU Neumann, NP Lam, H Dahari, DR Gretch, TE Wiley, TJ Layden, ...
Science 282 (5386), 103-107, 1998
The role of a mutant CCR5 allele in HIV–1 transmission and disease progression
Y Huang, WA Paxton, SM Wolinsky, AU Neumann, L Zhang, T He, S Kang, ...
Nature medicine 2 (11), 1240-1243, 1996
Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection
SM Wolinsky, BTM Korber, AU Neumann, M Daniels, KJ Kunstman, ...
Science 272 (5261), 537-542, 1996
Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy
G Gorochov, AU Neumann, A Kereveur, C Parizot, T Li, C Katlama, ...
Nature medicine 4 (2), 215-221, 1998
A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation
LG Kostrikis, Y Huang, JP Moore, SM Wolinsky, L Zhang, Y Guo, ...
Nature medicine 4 (3), 350-353, 1998
Dose‐dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa
NP Lam, AU Neumann, DR Gretch, TE Wiley, AS Perelson, TJ Layden
Hepatology 26 (1), 226-231, 1997
Influence of delayed viral production on viral dynamics in HIV-1 infected patients
JE Mittler, B Sulzer, AU Neumann, AS Perelson
Mathematical biosciences 152 (2), 143-163, 1998
Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon α2a
S Zeuzem, J Lee, E Herrmann, J Fricke, AU Neumann, M Modi, G Colucci, ...
Gastroenterology 120 (6), 1438-1447, 2001
Antiviral action of ribavirin in chronic hepatitis C
JM Pawlotsky, H Dahari, AU Neumann, C Hezode, G Germanidis, ...
Gastroenterology 126 (3), 703-714, 2004
Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication
M Bouvier‐Alias, K Patel, H Dahari, S Beaucourt, P Larderie, L Blatt, ...
Hepatology 36 (1), 211-218, 2002
Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines
RI Connor, BTM Korber, BS Graham, BH Hahn, DD Ho, BD Walker, ...
Journal of virology 72 (2), 1552-1576, 1998
The stage-structured predator–prey model and optimal harvesting policy
X Zhang, L Chen, AU Neumann
Mathematical Biosciences 168 (2), 201-210, 2000
Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virus
AU Neumann, NP Lam, H Dahari, M Davidian, TE Wiley, BP Mika, ...
The Journal of infectious diseases 182 (1), 28-35, 2000
Interferon (IFN)–γ–inducible protein–10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-α2a and ribavirin for chronic …
AI Romero, M Lagging, J Westin, AP Dhillon, LB Dustin, JM Pawlotsky, ...
The Journal of infectious diseases 194 (7), 895-903, 2006
Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations
JM Pawlotsky, G Germanidis, AU Neumann, M Pellerin, PO Frainais, ...
Journal of Virology 72 (4), 2795-2805, 1998
IP‐10 predicts viral response and therapeutic outcome in difficult‐to‐treat patients with HCV genotype 1 infection
M Lagging, AI Romero, J Westin, G Norkrans, AP Dhillon, JM Pawlotsky, ...
Hepatology 44 (6), 1617-1625, 2006
Global stability and periodic solution of the viral dynamics
X Song, AU Neumann
Journal of Mathematical Analysis and Applications 329 (1), 281-297, 2007
HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment
AU Neumann, R Tubiana, V Calvez, C Robert, TS Li, H Agut, B Autran, ...
Aids 13 (6), 677-683, 1999
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20